|
|
Effects of Dexmedetomidine combined with Lidocaine on oxidative stress and inflammatory response in laparoscopic hysterectomy patients |
ZHANG Nu XU Liansheng |
Department of Anesthesiology, the First People′s Hospital of Yibin, Sichuan Province, Yibin 664000, China |
|
|
Abstract Objective To expiore the effects of Dexmedetomidine combined with Lidocaine on oxidative stress and inflammatory response in patients with laparoscopic total hysterectomy. Methods One hundred and twenty patients with laparoscopic total hysterectomy in gynaecology of the First People′s Hospital of Yibin from September 2014 to October 2017 were selected as the subjects. According to the random digital table method,120 patients were divided into group A, B, C and control group, 30 cases in each group. Group A was treated with dexmedetomidin combined with Lidocaine by intravenous pump. Group B was treated with Dexmedetomidine by intravenous pump. Group C was treated with Lidocaine by intravenous pump. The control group treated with normal saline by intravenous pump. The inflammatory factors (IL-6, TNF-α) and oxidative stress indexes (H2O2, MDA and TAS) were monitored before administration (T1), at the end of operation (T2), 2 h after operation (T3) and 24 h after operation (T4). The incidence of postoperative adverse reactions was compared between the four groups. Results At T2, T3 and T4, levels of serum H2O2 and MDA, group A < group B< group C< control group, the difference between groups was statistically significant (P < 0.05). Levels of serum IL-6, TNF-α in group A < group B< group C< control group, and the TAS leves, group A> group B> group C> control group, the difference between groups was statistically significant (P < 0.05). The incidence of nausea and vomiting in group A was lower than that in group B and control group, the difference was statistically significant (P < 0.05). The incidence of somnolence and bradycardia in group A and B was higher than that in group C and control group, the difference was statistically significant (P < 0.05). Conclusion Dexmedetomidine combined with Lidocaine can alleviate the oxidative stress response and inflammatory response in patients with laparoscopic total hysterectomy. However, the incidence of somnolence and bradycardia increased after operation.
|
|
|
|
|
[1] 黄秀斌,周荣向,秦棠妮,等.改良腹腔镜辅助阴式子宫切除术行大子宫切除89例临床观察[J].实用妇产科杂志,2013,29(1):67-69.
[2] 李梦熊,邓柳枝,成娟,等.腹腔镜全子宫切除术与腹腔镜辅助阴式全子宫切除术后对盆底功能的影响[J].中华腔镜泌尿外科杂志,2014,8(5):326-328.
[3] Wang ZX,Huang CY,Hua YP,et al. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia:a randomized controlled trial [J]. British Journal of Anaesthesia,2014, 112(6):1055-1064.
[4] 王勇,蒋玲玲,程洁,等.右美托咪定对腹腔镜全子宫切除术患者氧化应激反应的影响[J].安徽医学,2015,19(6):1171-1174.
[5] Wang HL,Liu YY,Yan HD,et al. Intraoperative systemic lidocaine inhibits the expression of HMGB1 in patients undergoing radical hysterectomy [J]. Int J Clin Exp Med,2014,7(10):3398-3403.
[6] 李琨,裴卉,曹宇,等.参麻益智方对血管性痴呆模型大鼠海马形态及氧化应激的影响[J].北京中医药,2017,36(5):397-400.
[7] 张继晨,孟瑞霞,杜增利.右美托咪定对老年患者下肢手术中止血带所致氧化应激及炎症反应的影响[J].华中科技大学学报,2015,44(3):310-315.
[8] 宋颖,胡宝吉,陆晓英,等.右美托咪定对腹腔镜子宫切除术患者血流动力学及应激反应的影响[J].现代生物医学进展,2016,16(5):898-890.
[9] 邓志刚,赵平武.腹腔镜手术和氧化应激[J].腹腔镜外科杂志,2012,17(9):712-714.
[10] 张玉辉,高亚坤,肖连波,等.右美托咪定对心脏瓣膜手术围术期氧化应激和脑氧代谢的影响[J].中国煤炭工业医学杂志,2015,18(1):70-71.
[11] Aran T,Unsal MA,Guven S,et al. Carbon dioxide pneumoperitoneum induces systemic oxidative stress:a clinical study [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology,2012,161(1):80-83.
[12] 蒋丽丽,齐择优,李李,等.盐酸右美托咪定对H2O2诱导的肺泡巨噬细胞氧化应激的影响[J].中南大学学报,2013,38(10):1014-1019.
[13] 刘建,聂广宁,杨洪艳.过氧化氢诱导人卵巢颗粒细胞氧化应激模型的建立[J].广东医学,2017,38(7):986-989.
[14] Wang HL,Xing YQ,Xu YX,et al. The protective effect of lidocaine on septic rats via the inhibition of high mobility group box 1 expression and NF-κB activation [J]. Mediators Inflamm,2013,2013(3):570370.
[15] Koca U,Olguner ■G,Ergür BU,et al. The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis [J]. Scientific World Journal,2013,2013(4):292687.
[16] Ramirez MF,Tran P,Cata JP. The Effect of Clinically Therapeutic Plasma Concentrations of Lidocaine on Natural Killer Cell Cytotoxicity [J]. Reg Anesth Pain Med,2015,40(1):43-48.
[17] 房成,郭新玲,刘和平,等.不同麻醉药物对围术期食管癌根治术患者血清中细胞因子水平及血液流变学的影响及临床意义[J].中国医药导报,2012,9(31):90-91.
[18] 尚颖,赵立元,陆景坤.炎性细胞因子与胃癌的关系[J].中国药科大学学报,2015,46(1):123-128.
[19] 吕保来,吕继锋,郭珂清,等.利多卡因联合尼莫地平预防颅内动脉瘤术后脑血管痉挛的临床疗效观察[J].现代生物医学进展,2016,16(21):4124-4127.
[20] Xu SQ,Li YH,Wang SB,et al. Effects of intravenous lidocaine,dexmedetomidine and their combination on postoperative pain and bowel function recovery after abdominal hysterectomy [J]. Minerva Anestesiol,2017,83(7):685.
[21] Li B,Li Y,Tian S,et al. Anti-inflammatory Effects of Perioperative Dexmedetomidine Administered as an Adjunct to General Anesthesia:A Meta-analysis [J]. Sci Rep,2015,5:12342. |
|
|
|